A Phase 3, Multi-centre, Open-label, Extension Study to Investigate the Long-term Safety of SPD422 in Japanese Adults With Essential Thrombocythaemia
A Phase 3, Multi-centre, Open-label, Extension Study to Investigate the Long-term Safety of SPD422 in Japanese Adults With Essential Thrombocythaemia
The purpose of this study is to provide SPD422 to subjects who completed Study SPD422 308 and, in the opinion of the Investigator, will continue to benefit from treatment.
Inclusion Criteria:
Honkomagome 3-18-22, Bunkyo-ku 13 113-8677, Japan
Sendagi 1-1-5, Bunkyo-ku 13 113-8603, Japan
Chuo-ku Inohana 1-8-1, Chiba-shi 12 260-8677, Japan
Isehara-shi, Kanagawa 259-1143, Japan
Showa-machi 3-39-15, Maebashi-shi 10 371-8511, Japan
Higashigaoka 2-5-1, Meguro-ku 13 152-8902, Japan
Suita-shi, Osaka 565-0871, Japan
Izunokuni-shi, Shizuoka 22 410-2295, Japan